Oracle Trims 546 Cloud Jobs While Arvato Deal Lifts Sovereign Cloud Credentials
Published on 09/23/2026 at 03:30 | Editorial boerse-global.de
Oracle is simultaneously expanding its data-center footprint at breakneck speed and cutting deep into the very teams that keep those operations running. The tension between those two impulses tells you more about the company's AI ambitions than any earnings call.
Reports emerged this week that the software giant eliminated 546 positions inside its America Cloud Infrastructure unit. According to an internal document, that amounts to roughly 7.6 percent of the division's tracked workforce. The cuts did not spare the technical core: 57 Level III software engineers and dozens of management roles were among those let go.
Growth Engine, Meet Cost Discipline
The timing is awkward. Cloud infrastructure revenue surged 121 percent year-over-year in the first quarter of fiscal 2027, yet Oracle had already shed around 21,000 jobs in the prior fiscal year. Trimming again in the American cloud division suggests margin pressure in the AI segment has reached a level that demands hard choices.
A fresh partnership announced just yesterday — a pharmacovigilance services collaboration with Wipro — offers a useful counterpoint. Under that arrangement, Wipro will lean on Oracle's Argus Business Process Services to handle adverse-event reporting and regulatory workflows in drug safety. Such software alliances shore up the operating business, but they do little to ease the strain building on the balance sheet.
The Capex Bill Comes Due
Oracle's hardware buildout is consuming enormous resources. Management is targeting between $90 billion and $95 billion in capital expenditure for the current fiscal year, against a free cash flow that recently turned negative to the tune of $5.4 billion. Even a $664 billion order backlog offers no guarantee when the financing of that infrastructure is making capital markets increasingly jittery.
Should investors sell immediately? Or is it worth buying Oracle?
On the equity side, the stock finished yesterday's session at EUR 130.40. It is down 22 percent since the start of the year and trades 53 percent below its 52-week high — a gap that reflects persistent skepticism about whether the company's massive upfront spending can convert into reliable free cash flow quickly enough.
A European Win in Sovereign Cloud
Not every headline this week was about retrenchment. Oracle also announced that IT services provider Arvato Systems will run the European Medicines Verification System on the Oracle EU Sovereign Cloud. The platform tracks pharmaceuticals end-to-end to keep counterfeit medicines out of European supply chains — a high-stakes, heavily regulated use case where data protection and uptime requirements are stringent.
The European edition of the platform is designed so that sensitive data never leaves the bloc and remains subject to local rules alone. For the US group, the mandate is a meaningful endorsement of its EU-specific infrastructure and strengthens its hand against rivals courting European enterprise customers who prioritize digital sovereignty.
Markets rewarded the news modestly. Oracle shares climbed 1.1 percent to EUR 130.98 in German trading, though they remain down 21 percent year-to-date. Investors continue to fixate on the capital intensity of the global data-center expansion and the risk that major projects slip behind schedule. Still, sustained demand for cloud solutions suggests the underlying growth trend in the operating business is intact.
Momentum Versus Restructuring
The latest quarterly figures back that up. Total revenue rose 30 percent to $19.3 billion in the first quarter of fiscal 2027, with the cloud segment expanding 62 percent. To meet that demand, management is pushing global expansion hard — adding capacity to existing sites and driving large partner-led projects such as Lighthouse, a new data-center campus in Wisconsin, while investing in local education initiatives to build community support.
Paying for all of it requires savings elsewhere. Roughly a week ago, management raised the cost of its restructuring plan for fiscal 2026 by about $700 million, bringing the total to approximately $2.8 billion. That plan includes job reductions, which prompted some analysts to adjust their models. BMO Capital Markets lowered its price target to $195 on September 11 while keeping an "Outperform" rating; other houses made similar modest revisions during September but stayed largely constructive on the stock.
Winning the Arvato contract shows Oracle is gaining ground in the strategically vital sovereign cloud niche. If the company can sustain that momentum while keeping restructuring costs in check, investor confidence should firm up. Until it demonstrates that its enormous investments generate dependable free cash flow, though, the balance-sheet risks will keep outweighing the growth story.
Ad
Oracle Stock: New Analysis - 23 September
Fresh Oracle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
